Thermo Fisher Scientific today terminated its agreement to acquire QIAGEN after the would-be buyer failed to persuade enough QIAGEN shareholders to approve the potentially $12.5 billion deal.
Cytiva notes that its magnetic mixing system can meet the many demands and constraints during buffer and cell culture media preparation.
Azenta Life Sciences addresses cryopreservation scalability and standardization challenges.
Asahi Kasei and Axolabs will collaborate to build an oligo GMP manufacturing facility spanning an area of 59,000 square feet in Berlin.
Currently, FDA guidance requires biotech companies to use multiple assays to address genetic stability requirements. This traditional package of assays is costly, time-consuming, and often…
Regulators advise resident time distribution (RTD) studies as a way to address issues between batch processing and continuous manufacturing of biologics.
When testing sensors in upstream bioprocessing, electrochemical sensors were more accurate than optical pH sensors, but less accurate as a batch of cells aged.
Workflow design and data management are pivotal components of cell and gene therapy research and development. Advances in artificial intelligence, informatics, and automation have made…
A new study has identified differential gene-network changes characteristic of the three most prevalent molecular subtypes of breast cancer, Luminal A, Luminal B, and the…
From the keynotes to the tracks, conversations around AI-based applications were top of mind at this year’s meeting.
In this webinar, Jeff Coller, PhD, will describe a new therapeutic technique that enhances mRNA translation. This technology has numerous clinical applications and works by…
